Diabetes Metab J.  2017 Apr;41(2):152-153. 10.4093/dmj.2017.41.2.152.

Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30)

• Kong SH
• Koo BK
• Moon MK

• KMID: 2376779
• DOI: http://doi.org/10.4093/dmj.2017.41.2.152

Abstract

No abstract available.

MeSH Terms

Diabetes Mellitus, Type 2*
Dyslipidemias*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*

Reference

1. Kong SH, Koo BK, Moon MK. Efficacy of moderate intensity statins in the treatment of dyslipidemia in Korean patients with type 2 diabetes mellitus. Diabetes Metab J. 2017; 41:23–30.

2. World Health Organization. World Health Statistics 2016: monitoring health for the SDGs. Geneva: World Health Organization;2016.

3. Statistics Korea. The cause of death statistics in the Republic of Korea, 2015. Daejeon: Statistics Korea;2016.

4. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(25):Suppl 2. S49–S73.

5. Liao JK. Safety and efficacy of statins in Asians. Am J Cardiol. 2007; 99:410–414.

6. Lee E, Ryan S, Birmingham B, Zalikowski J, March R, Ambrose H, Moore R, Lee C, Chen Y, Schneck D. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin Pharmacol Ther. 2005; 78:330–341.

7. Kwon JE, Kim Y, Hyun S, Won H, Shin SY, Lee KJ, Kim SW, Kim TH, Kim CJ. Cholesterol lowering effects of low-dose statins in Korean Patients. J Lipid Atheroscler. 2014; 3:21–28.

8. Birmingham BK, Bujac SR, Elsby R, Azumaya CT, Zalikowski J, Chen Y, Kim K, Ambrose HJ. Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States. Eur J Clin Pharmacol. 2015; 71:329–340.